HighGravityData

American Eagle Outfitters — Dec 4, 2024 release

Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000950170-24-133307
Open on SEC.gov ↗
Showing in the filing
GAAP Basis
“$410”
Period
No period stated
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 12
Capital expenditures for FY2024
“$225 to $245 million”
Add: Impairment, Restructuring and Other Cha…
“$18”
Comparable Sales for Q4 FY2025
“up approximately 1%”
Comparable Sales for Q4 FY2024
“up approximately 1%”
Total Revenue for Q4 FY2024
“down 4%”
Operating Income for Q4 FY2024
“$125 to $130 million”
SG&A for Q4 FY2024
“expected to leverage”
Comparable Sales Growth for FY2024
“approximately 3%”
Total Revenue for FY2024
“up 1%”
Adjusted Operating Income for FY2024
“$428 to $433 million”
GAAP Basis
“$410”
Non-GAAP Basis
“$428”
Exhibit 99.1 · the passage around this item
… earlier in the release
                                                  GAAP to Non-GAAP Reconciliation   Fiscal 2024 Guidance   (Dollars in millions)     Operating     Income     Low End   High End   GAAP Basis $ 410   $ 415   Add: Impairment, Restructuring and Other Charges (1) $ 18   $ 18   Non-GAAP Basis $ 428   $ 433     (1) During the 13 weeks ended November 2, 2024, the Company recorded restructuring costs of $10.7 million related to employee severance, as well as impairment and restructuring costs of $6.8 million related to the pending sale of its Hong Kong retail operations to a third party buyer.       GAAP to Non-GAAP Reconciliation   53 Weeks Ended February 3, 2024   (Dollars in thousands)       Operating       Income   GAAP Basis   $ 222,717   % of Revenue     4.2 %         Add: Impairment, Restructuring and Other Charges   $ 152,645           Non-GAAP Basis   $ 375,362   % of Revenue     7.1 %   The Fiscal 2023 adjustments relate to certain inventory provisions, asset impairments, restructuring and other charges recognized in relation to Quiet Platforms, as well as the company’s international and corporate operations. Please refer to Note 16. “Impairment, Re
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.